Eos Management L.P. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,843 shares of the healthcare conglomerate's stock, valued at approximately $1,511,000.
Other large investors also recently made changes to their positions in the company. Swan Global Investments LLC grew its stake in UnitedHealth Group by 101.9% in the second quarter. Swan Global Investments LLC now owns 1,147 shares of the healthcare conglomerate's stock valued at $358,000 after acquiring an additional 579 shares during the period. Cidel Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 20.7% during the second quarter. Cidel Asset Management Inc. now owns 6,511 shares of the healthcare conglomerate's stock valued at $2,031,000 after buying an additional 1,118 shares during the last quarter. Crux Wealth Advisors lifted its position in UnitedHealth Group by 10.6% in the 2nd quarter. Crux Wealth Advisors now owns 2,002 shares of the healthcare conglomerate's stock valued at $625,000 after acquiring an additional 192 shares in the last quarter. Chicago Partners Investment Group LLC grew its position in shares of UnitedHealth Group by 26.4% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,606 shares of the healthcare conglomerate's stock valued at $1,347,000 after acquiring an additional 962 shares during the period. Finally, Sigma Investment Counselors Inc. increased its position in UnitedHealth Group by 5.8% in the second quarter. Sigma Investment Counselors Inc. now owns 14,130 shares of the healthcare conglomerate's stock worth $4,408,000 after buying an additional 769 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Down 0.0%
Shares of NYSE:UNH opened at $356.53 on Monday. The company has a market cap of $322.90 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50-day moving average price of $329.38 and a 200 day moving average price of $342.24. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Weiss Ratings reiterated a "sell (d+)" rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Truist Financial upped their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $385.13.
Get Our Latest Stock Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.